[Hypoglycemia].
1Department of Neurology, Yokohama Brain and Spine Center.
No Shinkei Geka. Neurological Surgery
|March 25, 2021
Summary
Hypoglycemia can cause acute hemiplegia, often mimicking stroke on MRI with internal capsule lesions. Brain damage from low blood sugar may spread from white matter tracts to the entire brain, but focal sign mechanisms remain unclear.
Area of Science:
- Neurology
- Radiology
- Metabolic Disorders
Background:
- Hypoglycemia can induce acute hemiplegia, a neurological deficit.
- Diffusion-weighted MRI in hypoglycemic hemiplegia commonly shows internal capsule lesions, resembling acute ischemic stroke.
- Hypoglycemic brain damage may initiate in white matter tracts and extend to gray matter.
Purpose of the Study:
- To review MRI findings in hypoglycemic hemiplegia.
- To discuss the potential progression of hypoglycemic brain damage.
- To highlight the unclear mechanisms behind focal neurological deficits in metabolic disorders.
Main Methods:
- Literature review of MRI findings in hypoglycemia.
- Analysis of reported cases of hypoglycemic hemiplegia.
- Discussion of current understanding of hypoglycemic brain injury patterns.
Main Results:
- The most frequent MRI finding is a hyperintense internal capsule lesion on diffusion-weighted imaging.
- Other reported MRI findings include lesions in the cerebral cortex, basal ganglia, white matter, and corpus callosum.
- Recent evidence suggests damage begins in large white matter tracts and disseminates throughout the brain.
Conclusions:
- Hypoglycemic hemiplegia presents with specific MRI patterns, often mimicking stroke.
- The spread of hypoglycemic brain damage from white matter to gray matter is increasingly recognized.
- The precise mechanisms causing focal neurological deficits in generalized metabolic brain disorders like hypoglycemia require further investigation.
Related Concept Videos
Hypoglycemia and Glucagon
514
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
514
Oral Hypoglycemic Agents: Glinides
382
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
382
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
370
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
370
Hormones Regulating Blood Glucose
5.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
5.4K
Diabetes: Symptoms, Diagnosis, and Complications
1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Glucose Homeostasis: Regulation of Blood Glucose
3.1K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.1K


